相似文献
1
Overcoming the Blood-Brain Barrier with an Implantable Ultrasound Device.
Clin Cancer Res. 2019 Jul 1;25(13):3750-3752. doi: 10.1158/1078-0432.CCR-19-0932. Epub 2019 May 10.
2
Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.
Expert Opin Drug Deliv. 2013 Jul;10(7):987-1001. doi: 10.1517/17425247.2013.787987. Epub 2013 Apr 4.
3
Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
J Neurosurg. 2017 Apr;126(4):1351-1361. doi: 10.3171/2016.3.JNS151635. Epub 2016 Jun 10.
4
Ultrasound and Microbubble-Mediated Blood-Brain Barrier Disruption for Targeted Delivery of Therapeutics to the Brain.
Methods Mol Biol. 2018;1831:111-119. doi: 10.1007/978-1-4939-8661-3_9.
5
Enhanced brain distribution of carboplatin in a primate model after blood-brain barrier disruption using an implantable ultrasound device.
Cancer Chemother Pharmacol. 2016 Jan;77(1):211-6. doi: 10.1007/s00280-015-2930-5. Epub 2015 Dec 8.
6
Focused Ultrasonography-Mediated Blood-Brain Barrier Disruption in the Enhancement of Delivery of Brain Tumor Therapies.
World Neurosurg. 2019 Nov;131:65-75. doi: 10.1016/j.wneu.2019.07.096. Epub 2019 Jul 16.
7
Moving toward Noninvasive, Focused Ultrasound Therapeutic Delivery of Drugs in the Brain: Prolonged Opening of Blood-Brain Barrier May Not Be Needed.
Radiology. 2019 May;291(2):467-468. doi: 10.1148/radiol.2019190410. Epub 2019 Mar 26.
8
Modulation of blood-brain barrier permeability.
J Drug Target. 1996;3(6):417-25. doi: 10.3109/10611869609015962.
9
Targeted blood-to-brain drug delivery --10 key development criteria.
Curr Pharm Biotechnol. 2012 Sep;13(12):2328-39. doi: 10.2174/138920112803341815.
10
Recent Advances in Transcranial Focused Ultrasound (FUS) Triggered Brain Delivery.
Curr Drug Targets. 2017;18(11):1225-1232. doi: 10.2174/1389450117666161222160025.
引用本文的文献
1
Pharmacokinetic analysis of carboplatin and fluorescein brain retention following ultrasound-based blood-brain barrier opening.
Clin Cancer Res. 2025 Jun 10. doi: 10.1158/1078-0432.CCR-25-0080.
2
Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma.
Front Oncol. 2025 Mar 13;15:1507940. doi: 10.3389/fonc.2025.1507940. eCollection 2025.
3
Crossing the blood-brain barrier: emerging therapeutic strategies for neurological disease.
Lancet Neurol. 2025 Mar;24(3):246-260. doi: 10.1016/S1474-4422(24)00476-9. Epub 2025 Jan 22.
4
Review of Novel Surgical, Radiation, and Systemic Therapies and Clinical Trials in Glioblastoma.
Int J Mol Sci. 2024 Sep 30;25(19):10570. doi: 10.3390/ijms251910570.
5
Therapeutic ultrasound transducer technology and monitoring techniques: a review with clinical examples.
Int J Hyperthermia. 2024;41(1):2389288. doi: 10.1080/02656736.2024.2389288. Epub 2024 Aug 12.
6
Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas.
Nat Commun. 2024 Jun 6;15(1):4698. doi: 10.1038/s41467-024-48326-w.
7
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond.
Cancers (Basel). 2024 Jan 23;16(3):475. doi: 10.3390/cancers16030475.
8
Combining causal and correlative approaches to discover biomarkers of response to paclitaxel.
Oncotarget. 2024 Feb 8;15:117-122. doi: 10.18632/oncotarget.28549.
9
Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma.
Clin Cancer Res. 2024 Apr 15;30(8):1619-1629. doi: 10.1158/1078-0432.CCR-23-2367.
10
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.
Lancet Oncol. 2023 May;24(5):509-522. doi: 10.1016/S1470-2045(23)00112-2.
本文引用的文献
1
Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma.
Clin Cancer Res. 2019 Jul 1;25(13):3793-3801. doi: 10.1158/1078-0432.CCR-18-3643. Epub 2019 Mar 19.
2
Clinical trial of blood-brain barrier disruption by pulsed ultrasound.
Sci Transl Med. 2016 Jun 15;8(343):343re2. doi: 10.1126/scitranslmed.aaf6086.
3
Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.
Ultrasound Med Biol. 2012 Oct;38(10):1716-25. doi: 10.1016/j.ultrasmedbio.2012.04.015. Epub 2012 Jul 19.
4
MRI-guided disruption of the blood-brain barrier using transcranial focused ultrasound in a rat model.
J Vis Exp. 2012 Mar 13(61):3555. doi: 10.3791/3555.
5
MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits.
Ultrasound Med Biol. 2005 Nov;31(11):1527-37. doi: 10.1016/j.ultrasmedbio.2005.07.010.
Zotero 插件